Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer | SpringerLink
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients | British Journal of Cancer
Velocità di Filtrazione Glomerulare - eGFR
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
EGFR-TKIs resistance via EGFR-independent signaling pathways | Molecular Cancer | Full Text
Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer - Annals of Oncology
Setting the benchmark for tailoring treatment with EGFR tyrosine kinase inhibitors | Future Oncology
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
eGFR: l'indicatore della salute dei reni. I valori e cosa significa se è basso
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment | British Journal of Cancer
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation | EMBO reports
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
eGFR alto, basso e valori normali
Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations | Science Signaling
Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology
Frontiers | Five Technologies for Detecting the EGFR T790M Mutation in the Circulating Cell-Free DNA of Patients With Non-small Cell Lung Cancer: A Comparison
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs): Simple drugs with a complex mechanism of action? - Normanno - 2003 - Journal of Cellular Physiology - Wiley Online Library
Epidermal growth factor receptor mutations in lung cancer | Nature Reviews Cancer
Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology
Frontiers | Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer
Unraveling the differential impact of PAHs and dioxin-like compounds on AKR1C3 reveals the EGFR extracellular domain as a critical determinant of the AHR response - ScienceDirect
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
